EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sugar Addiction and BED: Elucidating Pathological Mechanisms and Therapeutic Strategies

Yingyu Yang, Zishu Yang, Zihui Zhou

BIO Web of Conferences · 2026 · 237 · 01009

DOI: 10.1051/bioconf/202623701009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIO Web of Conferences, online erschienen am 10.06.2026. Verfasst von Yingyu Yang und 2 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the lack of systematic comparisons of neurobiological mechanisms and translatable therapeutic strategies between sugar addiction and binge eating disorder (BED), and the urgent need to address sugar-related metabolic and psychiatric comorbidities, this review aims to fill this gap and highlight the clinical and public health relevance of this comparison. This review examined the neurobiological parallels between sugar addiction and binge eating disorder (BED), highlighting shared dysregulations in dopaminergic, opioid, and GLP-1 systems, particularly within prefrontal-striatal-limbic circuits. Based on shared dysregulations in reward circuitry , opioid system downregulation , and hypothalamic POMC neuron dysfunction, we discussed the potential of repurposing investigational BED pharmacotherapies—such as lisdexamfetamine, naltrexone/bupropion, GLP-1 receptor agonists, and topiramate-for sugar addiction treatment. These agents are proposed to modulate neurotransmitter release, receptor activity, and neural network function to reduce cravings, impulsive feeding, and reward-seeking behaviors. Despite its high prevalence and significant adverse health consequences, sugar addiction remains unrecognized in major diagnostic systems (e.g., DSM-5 or ICD-11), limiting targeted therapeutic development. We underscore the necessity for additional mechanistic investigations and stringently designed clinical trials to transform these initial observations into validated, evidence-based treatment approaches. Future work should incorporate biotechnology-enabled approaches, such as neurocircuit-specific intervention strategies, biomarker-guided patient stratification, and rigorously designed clinical trials, to validate and translate these preliminary findings into evidence-based treatments.

Zitieren

APA

Yang, Y., Yang, Z., & Zhou, Z. (2026). Sugar Addiction and BED: Elucidating Pathological Mechanisms and Therapeutic Strategies. BIO Web of Conferences, 237, 01009. https://doi.org/10.1051/bioconf/202623701009

Vancouver

Yang Y, Yang Z, Zhou Z. Sugar Addiction and BED: Elucidating Pathological Mechanisms and Therapeutic Strategies. BIO Web of Conferences. 2026;237:01009. doi:10.1051/bioconf/202623701009

BibTeX
@article{Yang2026,
  author = {Yang, Yingyu and Yang, Zishu and Zhou, Zihui},
  title = {Sugar Addiction and BED: Elucidating Pathological Mechanisms and Therapeutic Strategies},
  journal = {BIO Web of Conferences},
  year = {2026},
  volume = {237},
  pages = {01009},
  doi = {10.1051/bioconf/202623701009}
}
Kostenlos starten →